What changed
Adjusted EPS of $0.22 topped the $0.21 consensus by $0.01, a 5.6% beat. Net sales came in at $1,698M, up 4.6% YoY (5.2% organic), with net income of $203M. Management raised FY2026 adjusted EPS guidance to $0.81–$0.83 and lifted the free cash flow outlook to $525M–$550M. The top-line print reflected a return to growth, with VWR Distribution Services organic sales accelerating to 5.8% and Bioscience Medtech Products returning to organic growth at 3.6%.
Why it matters
Adjusted EPS of $0.22 topped the $0.21 consensus by $0.01, a 5.6% beat. Net sales came in at $1,698M, up 4.6% YoY (5.2% organic), with net income of $203M. Management raised FY2026 adjusted EPS guidan